This is Part Two of our Psychedelic Science series. Click here for Part One, here for Part Three, and here for Part Four. It may seem counterintuitive to treat addiction with a drug that the Drug ...

Lysergic acid diethylamide (LSD) and psilocybin are now used on a limited basis in the treatment of anxiety and major depressive disorders. Prior to being administered, patients, most of whom report ...

Psychedelic-assisted therapy requires the educated know-how of what compounds you’re dealing with, especially if an individual is embarking on a microdose regimen. As little as a few micrograms of one ...

Before he died last year, Roland Griffiths was arguably the world’s most famous psychedelics researcher. Since 2006, his work has suggested that psilocybin, found in magic mushrooms, can induce ...

The next-generation psychedelics R&D business is up and running, as BetterLife Pharma Inc. BETRF’s lead drug candidate LSD analog BETR-001 has shown positive results in a study assessing it as a ...

Using classic psychedelic drugs does not raise the risk for mental health problems; on the contrary, it may offer some protection, new research suggests. Among 130,152 representative US adults, ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

Researchers analyzed the similarities and differences between a near-death experience (NDE) while in a coma and the experience induced by a psychedelic drug. Despite the common themes that emerged, ...